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Abstract 
Background: According to the World Health Organization, air pollution is closely associated with climate change 
and, in particular, with global warming. In addition to melting of ice and snow, rising sea level, and flooding of coastal 
areas, global warming is leading to a tropicalization of temperate marine ecosystems. Moreover, the effects of air pol-
lution on airway and lung diseases are well documented as reported by the World Allergy Organization.
Methods: Scientific literature was searched for studies investigating the effect of the interaction between air pollu-
tion and climate change on allergic and respiratory diseases.
Results: Since 1990s, a multitude of articles and reviews have been published on this topic, with many studies con-
firming that the warming of our planet is caused by the “greenhouse effect” as a result of increased emission of “green-
house” gases. Air pollution is also closely linked to global warming: the emission of hydrocarbon combustion products 
leads to increased concentrations of biological allergens such as pollens, generating a mixture of these particles called 
particulate matter (PM). The concept is that global warming is linked to the emission of hydrocarbon combustion 
products, since both carbon dioxide and heat increase pollen emission into the atmosphere, and all these particles 
make up PM10. However, the understanding of the mechanisms by which PM affects human health is still limited. 
Therefore, several studies are trying to determine the causes of global warming. There is also evidence that increased 
concentrations of air pollutants and pollens can activate inflammatory mediators in the airways. Our Task Force has 
prepared a Decalogue of rules addressing public administrators, which aims to limit the amount of allergenic pollen 
in the air without sacrificing public green areas.
Conclusions: Several studies underscore the significant risks of global warming on human health due to increas-
ing levels of air pollution. The impact of climate change on respiratory diseases appears well documented. The last 
decades have seen a rise in the concentrations of pollens and pollutants in the air. This rise parallels the increase in 
the number of people presenting with allergic symptoms (e.g., allergic rhinitis, conjunctivitis, and asthma), who often 
require emergency medical care. Our hope is that scientists from different disciplines will work together with institu-
tions, pharmaceutical companies and lay organizations to limit the adverse health effects of air pollution and global 
warming.
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Background
Climate change is already underway and is expected to 
continue in the next decades: temperatures are increas-
ing, global precipitation patterns are changing, ice and 
snow are melting, and global average sea level is ris-
ing. Moreover, the impact of global warming on human 
health has been documented by several reports from 
the World Health Organization (WHO) [1], which illus-
trate that a major concern about this phenomenon is 
the increase in air pollution levels. In this respect, the 
last report of the European Environment Agency (EEA) 
indicates that up to 96% of the urban population in the 
European Union are exposed to particulate and fine dust 
levels in excess of threshold values [2]. In addition to air 
pollution produced by hydrocarbon combustion emis-
sions, there is another issue: the formation of particles 
related to global warming, and the presence of gases, 
such as ozone, with generation of a mixture of particles 
in the atmosphere, called particulate matter (PM) or 
particle pollution. Environmental PM is a heterogene-
ous mixture of particles produced by various processes, 
whose size ranges from 2.5 to 10 μm. The fine particulate 
fraction (PM2.5) (also known as “fine particles”) consists 
of particles with a size of 2.5 microns (or smaller), while 
the ultrafine particulate fraction (also known as “ultrafine 
particles”) consists of particles with a size smaller than 
0.1  μm. The latter has a variable chemical composition, 
with the highest volatility, which is obviously due to its 
smaller size. It should also be noted that, although the 
ultrafine fraction represents less than 1% of the particu-
late mass, it is suspected of causing the greatest harm to 
the exposed population [3–6]. Importantly, this particu-
late fraction can reach the deepest parts of the bronchial 
tree, leading to major inflammatory and procarcinogenic 
effects on the bronchial mucosa [6]. Of note, PM is also 
involved in other diseases, including cardiovascular dis-
orders such as coronary heart disease and heart failure. 
These conditions are mainly due to the oxidative stress 
generated by the inflammatory response, with both short- 
and long-term adverse effects on human health through 
a variety of mechanisms [7–11]. In addition, it has been 
demonstrated that exposure to ozone and PM2.5 induces 
adverse health effects, including various pulmonary dis-
eases and lung cancer. Overall, air pollution-related 
global mortality has been associated with several emis-
sion sources; therefore, air pollution control can be an 
effective strategy to reduce mortality [12]. Both concen-
trations and chemical composition of PM show a large 
variability not only geographic, but also seasonal. PM 
concentrations are usually higher in urban areas than in 
rural areas. With regard to seasonal variability, PM levels 
increase significantly during the winter due to increased 
emissions from road traffic and residential heating, and 
decrease during spring and summer when pollen concen-
trations are typically highest [13].
Some particulates are naturally occurring and originate 
from volcanoes, dust storms, forest and grassland fires, 
living vegetation, and sea spray. Although most aerosols 
remain suspended in the atmosphere for short periods 
(typically between 4  days and a week), they can travel 
vast distances. Dust plumes from the Sahara often cross 
the Atlantic and reach the Caribbean. Winds sweep a 
mixture of Asian aerosols, including dust from the Gobi 
desert and pollution from China, to the east over Japan 
and toward the central Pacific Ocean. Smoke from wild-
fires in Siberia and Canada can go as far as the Arctic ice 
cap [11]. Sea spray from the Mediterranean Sea and min-
eral dust from Sahara in North Africa can contribute to 
the chemical composition of PM in Southern Europe [14, 
15].
Human activities, including the combustion of fos-
sil fuels in vehicles, power plants, and many industrial 
processes [10], can also generate significant amounts of 
particulates. Coal combustion in developing countries is 
the primary means to generate energy and heat homes. 
Although salt spray is the most common form of partic-
ulate in the atmosphere over the oceans, anthropogenic 
aerosols, i.e. those that are generated by human activities, 
currently account for about 10% of the total mass of aero-
sols in the atmosphere [11].
In recent years, air quality has improved in industrial-
ized Western countries, while it has worsened in devel-
oping countries. In Asia, for example, anthropogenic 
emissions have increased in recent decades with the 
rapid development of urbanization and industrializa-
tion. On the contrary, aerosol emissions have declined 
in North America and Europe with the relocation of fac-
tories to developing countries and with the adoption of 
more stringent clean air regulations in Western coun-
tries. However, it may be difficult to define the amount 
of air pollution in different areas of the world, since most 
aerosols remain suspended in the atmosphere for short 
periods, typically between 4 days and a week. PM parti-
cles in the atmosphere can move at 5 m (16.4 ft) per sec-
ond, and may travel thousands of kilometres in a week, 
making it difficult to accurately measure pollution levels; 
consequently, any predictions about the deterioration of 
air quality can be distorted by this initial bias, especially 
with regard to time.
Air pollution and climate change‑related health impacts
Global warming is a major public health emergency. 
Global temperature has risen markedly over the last 
50  years and is still rising, as demonstrated by warm-
ing of the oceans, rising sea levels, melting of glaciers, 
retreating of Arctic sea ice, and diminishing snow cover 
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in the Northern Hemisphere. Climate change is also 
associated with extreme weather events such as heat 
waves, droughts, floods, and hurricanes. These changes 
are probably due to increased emissions of greenhouse 
gases (namely, carbon dioxide, methane and nitrous 
oxide), largely from anthropogenic sources. Projections 
of future greenhouse gas emissions indicate a worsening 
of the situation with further increase in average tempera-
tures and temperature extremes by the end of the twenty-
first century [16].
A large body of evidence suggests that climate change 
have significant health impacts, both direct and indirect. 
Direct health impacts include morbidity and mortality 
associated with direct exposure to hazardous weather 
conditions such as heat waves, floods, cyclones, etc. Indi-
rect health impacts, which include the majority of climate 
change-related diseases, are mediated by environmental 
conditions which affect the spatial and temporal distri-
bution of aeroallergens, the generation and dispersion of 
air pollutants, and the population of disease-transmitting 
vectors like mosquitoes and ticks.
Several epidemiological studies have demonstrated 
a close association between global warming, air pollu-
tion and respiratory allergic diseases, such as bronchial 
asthma and rhinitis. Climate changes affect the quantity, 
quality, timing and distribution of aeroallergens [17]. 
The increased atmospheric carbon dioxide concentra-
tions due to fossil fuel burning stimulate the growth 
of plants, including allergenic species. On top of that, 
higher temperatures can lead to earlier and longer polli-
nation seasons, leading to increased pollen sensitization 
rate and symptom duration. Individuals with asthma are 
at increased risk of developing obstructive airway attacks 
when exposed to gaseous and particulate components of 
air pollution [17]. In addition, air pollution can modify 
the allergenic potential of pollens, especially in the pres-
ence of favourable weather conditions. Air pollution—
in particular PM, diesel exhaust particles (DEP), ozone, 
nitrogen dioxide, and sulfur dioxide—have been shown to 
have an inflammatory effect on the airways of susceptible 
subjects, causing increased mucosal permeability, facili-
tating the penetration and access of inhaled allergens to 
the cells of the immune system [18]. There are also data 
suggesting that air pollution can lead to the development 
of asthma. Therefore, climate change combined with air 
pollution may have severe impacts on respiratory health, 
especially in children.
Thunderstorms occurring during the pollen season 
have been shown to induce severe asthma attacks in 
pollinosis patients [18, 19]. The thunderstorm-related 
epidemics are limited to late spring and summer when 
there are high levels of pollen grains in the atmosphere. 
The main hypotheses for thunderstorm-related asthma 
claim that thunderstorms can concentrate pollen grains 
at ground level which rupture due to osmotic shock and 
release allergenic particles of respirable size into the 
atmosphere [19].
Rising temperatures, a higher concentration of carbon 
dioxide in the atmosphere, heavier rainfalls, and higher 
humidity induce faster proliferation of pollens, moulds, 
and fungi [20]. In addition, increases in humidity asso-
ciated with higher temperatures may encourage the 
growth of cockroaches, house dust mites, and moulds, 
and, thus, allergen load [17]. Higher temperatures can 
also induce the migration of stinging and biting insects 
into new environments, as well as increasing the pop-
ulation of existing insect species [19]. Indeed, climate 
changes and globalization are altering the distribution 
and consistency of allergenic species including venom-
ous insects. In particular, given the expansion of native 
species and the colonization of invasive ones, one can 
predict, despite the uncertainty of current models, that 
stinging Hymenoptera will pose new challenges in the 
future [21].
Many studies have reported the impact of climatic 
changes on the spatial and temporal distribution of 
infectious diseases such as vector-borne, rodent-borne, 
food-borne and water-borne diseases, including in par-
ticular malaria, tick-borne diseases, cholera and other 
diarrhoeal diseases. Importantly, several vector-borne 
diseases have emerged in Europe in recent years; these 
include vivax malaria, West Nile fever, dengue fever, Chi-
kungunya fever, Leishmaniasis, Lyme disease, and tick-
borne encephalitis [22, 23].
Chronic exposure to air pollution is also associated 
with pulmonary inflammation, chronic obstructive pul-
monary disease (COPD), and lung cancer. Several stud-
ies suggest that chronic exposure to outdoor air pollution 
increases the prevalence and incidence of COPD [24]. 
Moreover, among individuals with COPD, air pollution is 
associated with increased respiratory symptoms, loss of 
lung function, COPD exacerbations and higher mortality 
[24]. Air pollution is also linked to lung cancer, and the 
International Agency for Research on Cancer (IARC) has 
classified the particulate matter in outdoor air pollution 
as carcinogenic to humans [25].
Studies from across the world have consistently dem-
onstrated that exposure to particulate air pollution is 
associated with a host of cardiovascular diseases, includ-
ing myocardial ischaemia and infarctions, heart failure, 
arrhythmias, strokes and increased cardiovascular mor-
tality [26]. Acute exposure may contribute to plaque 
instability and trigger acute cardiovascular events, 
including myocardial ischaemia and infarction, stroke, 
heart failure, arrhythmias, and sudden death, particularly 
in high-risk subjects, while chronic exposure may favour 
Page 4 of 11Patella et al. Clin Mol Allergy  (2018) 16:20 
the development and progression of atherosclerosis and 
possibly of hypertension in the long term [27].
Finally, a number of studies have reported an asso-
ciation between air pollution and higher risk of neuroin-
flammation and neurodegeneration [28, 29]. In particular, 
there is some evidence that chronic exposure to airborne 
pollutants in the early years of life may contribute to neu-
rodegenerative disease processes including Alzheimer’s 
disease and Parkinson’s disease [30].
In summary, air pollution and climate change-related 
health impacts are enormous and are expected to increase 
during the next decades. As a result, also the social and 
economic costs of climate change are enormous and will 
increase in the future. Nevertheless, there is a relative 
scarcity of economic studies on the health impacts of cli-
mate change. Most studies have estimated the economic 
costs of extreme weather events or the impacts of climate 
change on respiratory diseases and infectious diseases 
(vector borne, water related, and food borne). However, 
these economic studies are heterogeneous in terms of 
objectives and methodology. To this end, a review has 
pointed out the need for climate change-specific health 
economic guidelines to provide a standardized approach 
and stimulate economic research [31]. A more recent 
review, conducted to evaluate the health costs result-
ing from human exposure to weather-related extreme 
events such as heat waves, droughts, floods, storms and 
hurricanes, has highlighted a lack of evidence about the 
potential cost-effectiveness of interventions that exploits 
the capacity of natural ecosystems to reduce exposure to 
extreme events, despite the observations that evidence 
that poor land management increases the vulnerability to 
these events [32]. However, all studies identified in this 
review indicate that the health costs associated with the 
impacts of extreme events are substantial. For example, 
six climate change-related events that struck the United 
States between 2000 and 2009, accounted for about $14 
billion in lost lives and health costs [33].
Mechanisms responsible for allergic and respiratory 
diseases
The mechanisms by which PM affects human health are 
still debated [34]. The atmosphere is the medium of tran-
sit not only for pollutant gases and particles, but also for 
a wide variety of biogenic materials of plant and animal 
origin. Among biogenic materials, there is the bioaero-
sol, which consists of different kinds of airborne particles 
such as viruses, bacteria, moulds, plant fibres, and also 
pollen with variable sizes, ranging from tens of nanom-
eters to a few hundreds of micrometers. These biological 
substances are involved in allergic and respiratory dis-
eases, and act both directly and indirectly on airway epi-
thelial cells. The increased concentration of pollen and air 
pollutants can activate different epithelial and immune 
cells in the airways, leading to the release of inflamma-
tory mediators [35]. However, the specific components 
and the mechanisms responsible for oxidative stress fol-
lowing exposure to PM are not fully understood. Direct 
oxidant production by air pollution particles in epithelial 
cells of the respiratory mucosa has been reported. This 
effect has been attributed to both organic components 
and a number of heavy metals (e.g., arsenic, cadmium, 
chromium, mercury, nickel, lead, and thallium). These 
metals have a wide distribution in the environment as a 
result of their multiple industrial, domestic, agricultural, 
medical, and technological applications, which raises 
many concerns about their potential effects on human 
health and the environment. The main consequences of 
oxidative stress include the activation of specific cellular 
reactions (including activation of kinases and transcrip-
tion factors), the release of inflammatory mediators, and 
eventually cell damage or apoptosis [36]. All this pro-
motes bronchial hyperreactivity as well as a decline in 
pulmonary function, increasing the risk of allergic sensi-
tisation, asthma, chronic obstructive pulmonary disease, 
and cancer. Recent epigenetic studies have shown that a 
number of genes controlling immune and inflammatory 
responses are sensitive to tropospheric ozone. Indeed, 
atmospheric pollutants like diesel exhaust particles 
[particulate] (DEPs) and ozone are directly involved in 
asthma pathogenesis [37]. Importantly, DEPs are a major 
component of traffic-related particulate air pollution in 
most urban areas. In addition, a number of evidence indi-
cates that DEPs may facilitate entry of allergens into the 
airways eliciting immunopathological response, and can 
also bind pollen, dog, cat, and house dust mite allergens 
[38–40]. Due to their very fine size, DEPs can facilitate 
the penetration of these allergens into the lungs, thereby 
increasing the amount of allergens interacting with the 
airway epithelium. It has also been demonstrated that 
DEPs can disrupt pollen particles causing the release of 
allergenic sub-pollen particles. Interestingly, a detailed 
analysis of pollen taken from air-polluted areas showed 
an increased amount of allergenic proteins with higher 
allergenic potential. In another study, comparing recent 
and decade-old pollen extracts, the recent pollen extract 
showed higher allergenic potency. In addition, the recent 
pollen extract obtained from the urban area had a higher 
allergenic potency than the recent pollen extract from the 
suburban area [39]. More recently, the same authors of 
the above study demonstrated that a recent pollen extract 
from an urban area significantly exposed to pollution 
and climate change was more effective at inducing tran-
sepithelial permeability and ROS production in cultured 
airway epithelial cells [41]. This DEPs ability seems to 
be strongly dependent on a range of variables. However, 
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the latest scientific findings indicate that DEPs are likely 
involved in exacerbations of already existing disease pro-
cesses, and not in the development of new diseases. The 
latter hypothesis is based on the enhancement of Th2-
dependent responses induced by DEPs [42]. Nonetheless, 
there are a variety of mechanisms involved in exposure 
to asthma triggers that do not depend on IgE-medi-
ated responses. These observations have been partially 
confirmed by epigenetic studies. Epigenetics refers to 
changes in gene expression that are not caused by altera-
tions in DNA sequences; these changes can be associated 
with environmental factors such road traffic and smoke 
pollution [43]. With regard to this issue, recent stud-
ies have been focused on mutation hotspots and DNA 
methylation, involving the so called CpG islands, which 
are located near the promoter region of many genes. In 
particular, one of these studies showed significant differ-
ences in methylation levels of CpG islands in eosinophils 
from asthmatic patients compared with non-asthmatic 
individuals, with the lowest levels of methylation in the 
subjects with asthma. This study also showed signifi-
cant associations between IgE and low methylation at 
36 loci concentrated in CpG islands [44]. In addition 
to the above, changes in histone acetyltransferase and 
deacetylase activity have been observed in cells from 
patients with lung disorders such as severe asthma and 
chronic obstructive pulmonary disease (COPD) [45]. 
Considering that the anti-inflammatory effects of gluco-
corticoids are dependent on histone deacetylase activ-
ity, this finding may be relevant for patients with severe 
asthma and COPD who are insensitive to glucocorticoid 
therapy. Indeed, it has been shown that glucocorticoid-
insensitive asthmatics have an increased activation of p38 
mitogen-activated protein kinase (MAPK), which can 
reduce the ligand-binding affinity of the glucocorticoid 
receptor (GR) leading to impaired corticosteroid sensi-
tivity [46]. This can contribute to poor disease control in 
patients with chronic asthma and COPD. In this respect, 
it is worth mentioning that also disruption of circadian 
rhythms may impair asthma control. For example, the 
degree of asthma control has been shown to strongly 
correlate with sleep quality. In fact, individuals whose 
asthma is not well controlled take longer to fall asleep, 
awake more often, and spend more time awake during 
the night compared to those with well controlled asthma 
[47]. Interestingly, many other immunological and aller-
gic diseases, including allergic rhinitis, atopic eczema, 
chronic urticaria, and rheumatoid arthritis, show a cir-
cadian rhythm in the intensity of symptoms and disease 
severity, which suggests the importance of chronotherapy 
as a strategy to achieve symptoms control [47].
Of note, not all studies support the hypothesis that air 
pollution has a greater deleterious effect on asthmatic 
patients compared to non-asthmatic individuals. How-
ever, experimental and clinical studies have demonstrated 
that asthmatic patients have an increased inflammatory 
response to air pollutants like PM2.5-10 [48] and espe-
cially ozone [49]. Several factors may contribute to the 
adverse effects of ozone in asthmatic patients by impair-
ing innate immune responses [50].
Epidemiological studies indicate that older people are 
at higher risk of hospitalisation. In particular, increased 
exposure to air pollution has been linked to increased 
mortality, hospital admissions and emergency-room 
visits in the elderly [51]. These effects are mainly due to 
exacerbations of chronic diseases or to respiratory tract 
infections (e.g., pneumonia), and may be modulated by 
ambient temperature as demonstrated by several stud-
ies showing that the elderly are particularly vulnerable 
to heat waves. In general, it seems that elderly subjects 
are more vulnerable to PM than to other pollutants, with 
greater effects on cardiorespiratory mortality and acute 
hospital admissions [51]. The elderly are at greater risk 
than other age groups due to their enhanced suscepti-
bility to air pollutants as a result of normal and patho-
logical ageing and related processes. In fact, ageing has 
been associated with a decline in immune defences and 
respiratory function, resulting in a higher predisposition 
to respiratory infections. Moreover, among the chronic 
diseases that affect the elderly population, COPD and 
asthma can accelerate pulmonary function decline and 
increase the risk of mortality [52].
The relationship between short-term exposure to air 
pollution and cardiorespiratory morbidity and mortality 
in the elderly is well-documented. A systematic review 
and meta-analysis conducted by Bell et  al. [53] found 
strong, consistent evidence of a higher risk of PM-asso-
ciated hospitalisation and death in the elderly. The results 
of this meta-analysis showed that a 10  μg/m3 increase 
in PM10 exposure was associated with a higher risk of 
death of 0.64% (95% confidence interval (CI) 0.50, 0.78) 
for older populations compared with 0.34% (95% CI 0.25, 
0.42) for younger populations. In another systematic 
review by Bell et al. [54], regarding sensitivity to mortality 
or hospital admission from short-term ozone exposure, 
mortality risk was also higher for older persons (1.27%; 
95% CI 0.76–1.78) than for younger persons (0.60%; 95% 
CI 0.40–0.80).
Further evidence of an association between air pollu-
tion and mortality in the elderly was provided by another 
study, which showed that a 3–4% increase in daily deaths 
for all causes and for cardiovascular disease in the elderly 
was associated with an increase in fine particulate mat-
ter and sulfur dioxide from the 10th to the 90th percen-
tile [55]. The increase in mortality was even higher (6%) 
for respiratory deaths. Cardiovascular deaths were also 
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associated with levels of carbon monoxide (4% increase 
in daily deaths). On the contrary, the associations 
between air pollution and mortality were not statistically 
significant in children under 5 years. In summary, there 
was a significant trend of increased risk of death based 
on age, with effects more evident for individuals over 
65 years old. The effect of air pollution was even larger in 
areas with higher socioeconomic level [55].
With regard to the effects of socioeconomic vulner-
ability on the risk of mortality in populations exposed 
to high PM concentrations, an Asian study showed that 
economic inactivity had the greatest influence on the risk 
of mortality (Table  1) [56]. People who were economi-
cally inactive had a 5.5% higher risk of all-cause mortal-
ity and a 5.6% higher risk of cardiorespiratory mortality 
from a 10  μg/m3 increase in PM10–2.5 compared with 
those who were employed during a day with an extreme 
dust event. Also, the elderly and non-married people had 
higher risks of mortality during days with extreme dust 
events. People aged 65 years and older had a 4.4% higher 
risk of all-cause mortality and a 5.3% higher risk of car-
diorespiratory mortality compared with those who were 
under the age of 65. People who were not married had a 
4.1% higher risk of all-cause mortality and a 4.7% higher 
risk of cardiorespiratory mortality than those married 
[56].
Importantly, it has been observed that antioxidant met-
abolic pathways become increasingly compromised with 
ageing. Older people are also particularly sensitive to the 
short-term effects of ozone exposure [50]. It is becoming 
increasingly clear that ageing is strongly associated with 
senescence of the immune system [57–61]. To this regard, 
outdoor traffic pollution exposure is the most impor-
tant predictive factor for asthma in the elderly [62–66]. 
Indeed, higher levels of outdoor and indoor exposures to 
DEPs, combined with obesity and atopic state, are associ-
ated with inadequate asthma control in the elderly [67]. 
There is also evidence that heat waves are associated with 
an increased risk of hospitalisation and higher mortality 
in the elderly [68]. In particular, two studies have shown 
that severe cardiovascular and respiratory diseases can 
be induced by the elevated air pollution associated with 
heat waves, especially in the elderly [69, 70].
Environmental pollution exposure significantly 
increases the risk of respiratory diseases, particularly 
asthma. Both adult and young patients, smokers or non-
smokers, are prone to acute asthma attacks as a result of 
greater exposure to air pollution. In particular, children 
from low-income backgrounds have been found to be 
more susceptible to acute asthma attacks due to air pollu-
tion. However, larger studies are required to confirm the 
relevance of these interactions, and to further explore the 
risk factors for asthma associated with long-term air pol-
lution exposure in patients of different ages. Moreover, 
when differentiating between the effects of various risk 
factors, it is important to remember that asthma is not 
a single disease [71]. In addition, the risk of both allergic 
and non-allergic asthma seems to increase with increas-
ing BMI as previously reported in children [72]. Finally, 
associations between early-life environmental exposures 
and asthma have been found in non atopic subjects [73, 
74].
Recently, air pollution has also been associated with 
increased plasma viscosity and cardiac functions abnor-
malities, mainly due to cardiac arrhythmias [75–77]. 
Therefore, elderly patients are more susceptible than 
younger patients to the adverse effects of climate change 
due to their higher incidence of cardiovascular disease. 
Another important issue is the relationship between cli-
mate change and microbial infections. It has been sug-
gested that the rapid and intense climate changes related 
to global warming can create conditions that promote 
the spread of epidemic diseases. For instance, heavy rain-
falls increase the availability of breeding places for pests 
such as bugs and rats, which contaminate drinking water 
supplies. Moreover, parasitic and viral diseases transmit-
ted by mosquitoes are very sensitive to climate changes 
[78–80].
Other mechanisms involved in climate change include 
air temperature increases in urban areas, a phenomenon 
called “heat island.” This effect is particularly relevant 
for people living in these areas, especially those who 
are affected by cardiovascular and/or respiratory dis-
eases. It also has a significant impact on the most fragile 
Table 1 Effect modification of socioeconomic vulnerability 
for  10  mg/m3 increase of  PM10-2.5, with  95% confidence 
interval. Modified from Ho et al. [56]
Italic text indicates results with significant difference between vulnerable and 
non-vulnerable groups
Socioeconomic 
vulnerability (individual 
level)
OR at lag 0 (all 
cause mortality)
OR at lag 0 
(cardiorespiratory 
mortality)
Age
 > 65 1.044 [1.029, 1.059] 1.053 [1.029, 1.078]
 < 65 1.047 [0.994, 1.103] 1.045 [0.920, 1.186]
Gender
 Female 1.057 [1.014, 1.102] 1.062 [0.998, 1.131]
 Male 1.033 [1.018, 1.049] 1.030 [1.009, 1.052]
Socioeconomic status
 Economically inactive 1.055 [1.039, 1.070] 1.056 [1.030, 1.081]
 Economically active 1.024 [0.992, 1.057] 1.019 [0.974, 1.066]
Marital status
 Non-married 1.041 [1.018, 1.065] 1.047 [1.004, 1.093]
 Married 1.034 [1.013, 1.056] 1.030 [1.003, 1.056]
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population groups (e.g., elderly and poor people). In fact, 
these people have less access to air conditioning and 
tend to stay more outdoors (e.g., streets, squares) where 
they are more exposed to urban overheating. In addi-
tion, exposure to outdoor air pollution combined with 
exposure to allergenic pollen can trigger severe asthma 
attacks. A reduction in emergency hospital admissions 
after the implementation of prevention programs sup-
ports the view of a causal link between air pollution and 
exacerbations of chronic respiratory diseases [80].
The SIAAIC task force on air pollution and climate change: 
the decalogue “Allergy Safe Tree”
In April 2014, the Italian Society of Allergology, Asthma 
and Clinical Immunology (Società Italiana di Allergolo-
gia, Asma ed Immnunologia Clinica, SIAAIC) estab-
lished the Task Force (TF) on “Air Pollution and Climate 
Change.”
The SIAAIC TF launched a project divided into 3 suc-
cessive steps. The first step involved the establishment of 
a multidisciplinary expert group, including high-profile 
academic, institutional and associative figures working 
in the field of “Air Pollution and Climate Change” at the 
legal, environmental and institutional levels. SIAAIC 
Allergists and Clinical Immunologists were clearly 
involved in this group. The second step of the project 
(“exploratory step”) included the collection of national 
and European data on climate and environmental 
changes. The third step of the TF’s work, still underway, 
focused on the preparation of a final document (Report 
or Guidelines) to raise awareness about “Air Pollution 
and Climate Change” and their impact on Immunological 
and Allergic Diseases. The TF also planned the produc-
tion of a “synthetic” version of the document intended for 
the public, as well as the preparation of a Decalogue to 
be sent to local administrators with a set of rules aimed 
at protecting public health. Starting from this initial 
proposal, and as a result of its regular activities during 
these years, the Task Force on Air Pollution and Climate 
Change of the Italian Society of Allergology, Asthma and 
Clinical Immunology (SIAAIC) has proposed a National 
Healthcare Program to help the cities’ public adminis-
trations in choosing non allergenic trees in public parks. 
The “DECALOGUE: ALLERGY SAFE TREE” document 
suggests how to use non allergenic trees in gardens and 
public parks [81, 82] (Fig. 1).
As the subtitle indicates, the Decalogue plans to carry 
out a prevention campaign to reduce the amount of pol-
len in the air without sacrificing public green areas. To 
this end, the document adopted by the SIAAIC TF pro-
poses “simple actions” concerning the management and 
care of plants, targeting several factors affecting allergen 
concentrations, including the “pollen calendar,” namely 
the recording of seasonal peaks of airborne pollen con-
centrations. The SIAAIC TF believes that compliance 
with the provisions of the Decalogue can help meet the 
campaign goal, that is, reducing the concentrations 
of airborne allergenic pollen in the cities. Among the 
forthcoming activities, the TF is preparing aerobiology 
courses, as well as the creation of a national SIAAIC aer-
obiology network for the monitoring of allergies across 
the country.
Behind the initiatives of the SIAAIC TF on “Air Pollu-
tion and Climate Change,” there is the authors’ opinion, 
which is supported by recent studies, that the prevention 
of allergies can be implemented by public administra-
tions through a careful choice of non allergenic trees and 
plants. Likewise, a careful selection of ornamental plants 
can contribute to reduce pollen levels in the private sec-
tor (condos, sports, malls and industrial green areas) 
[77]. These aspects are of high relevance as parks and 
gardens are primarily visited by both children and elderly 
people, who are susceptible to allergic sensitisation and 
respiratory diseases. Finally, allergen exposure within 
the parks is particularly dangerous when combined with 
climate conditions characterized by rising temperatures 
that can promote pollen production, taking into account 
the fact that urbanization and high levels of vehicle emis-
sions correlate with a higher frequency of pollen-induced 
respiratory allergy [4].
Conclusion
The effects of global warming on human health are sup-
ported by many official documents which emphasize 
the importance of air pollution on the rising incidence 
of many respiratory diseases. Climate change, by modi-
fying major climatic variables, influences directly and 
indirectly the formation of air pollutants. Both global 
warming and solar radiation contribute to the formation 
of secondary pollutants in the atmosphere, especially 
tropospheric ozone. All these factors can explain, at least 
partly, the increasing incidence of respiratory and aller-
gic diseases in different parts of the world. Recent fore-
casts suggest that climate change will persist for several 
decades (IPCC 2013). It is likely that we will face the 
impact of climate change for at least the next 50  years. 
The effects of climate change are already here and their 
negative consequences cannot be easily avoided or pre-
vented. In many patients with respiratory diseases like 
asthma, symptomatic treatment with bronchodilators or 
inhaled corticosteroids is sufficient to control disease. 
However, there are patients who do not achieve control 
despite treatment with the best current therapy. This 
heterogeneity of asthma and allergic diseases is increas-
ingly appreciated based primarily on recent cluster analy-
ses, molecular phenotyping, biomarkers and differential 
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Fig. 1 Prevention campaign to reduce the amount of pollen in the air without renouncing to public parks and green spaces
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responses to targeted and non-targeted therapies [83]. 
This can be explained, at least in part, by different patient 
exposure to climate change and air pollution. A joint 
effort among scientists of different disciplines together 
with public administrations is highly desirable to limit 
present and future harm to human health as a result of 
interaction between climate change and air pollution.
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